Choosing the Right Biologic for the Right Patient With Severe Asthma
Abstract In this installment of the How I Do It series on severe asthma, we tackle the clinical conundrum of choosing the right biologic for the right patient with severe asthma. With six biologics now approved for use in this area comprising four different targeting strategies (anti-Ig E: omalizumab; anti-IL-5 and anti-IL-5-receptor: mepolizumab, reslizumab, and […]
Choosing the Right Biologic for the Right Patient With Severe Asthma Read Post »